Pierzynowski, Stefan G.
Wychowański, Piotr
Szczesny, Wiesław
Galloto, Robert
Zaworski, Kamil
Szkopek, Dominika
Woliński, Jarosław
Donaldson, Janine
Pierzynowska, Kateryna
Funding for this research was provided by:
Lund University
Article History
Received: 21 March 2025
Accepted: 28 May 2025
First Online: 4 June 2025
Declarations
:
: The authors of this manuscript have the following competing interests: Stefan Pierzynowski and Kateryna Pierzynowska are the owners of Anara AB, Sweden. Janine Donaldson is employed by Anara AB, Sweden. Piotr Wychowanski is the owner of the Specialized Private Implantology Clinic Wychowański Stomatology and MED Sp. z o.o. (Poland). Robert Gallotto is the founder and CEO of Anagram Therapeutics Inc. All other authors declare no competing interests.